BioMarin Pharmaceutical
BMRN
#1442
Rank
HK$93.32 B
Marketcap
HK$486.71
Share price
1.29%
Change (1 day)
-31.85%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2023 (TTM): HK$6.11

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is HK$6.04. In 2022 the company made an earnings per share (EPS) of HK$5.96 an increase over its 2021 EPS that were of -HK$2.72.

EPS history for BioMarin Pharmaceutical from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$6.112.39%
2022HK$5.96-319.62%
2021-HK$2.72-107.38%
2020HK$36.77-3485.71%
2019-HK$1.09-67.44%
2018-HK$3.34-34.85%
2017-HK$5.12-83.21%
2016-HK$30.49263.89%
2015-HK$8.3818.68%
2014-HK$7.06-28.91%
2013-HK$9.9334.74%
2012-HK$7.3793.88%
2011-HK$3.80-124.5%
2010HK$15.51
2009N/A-100%
2008HK$2.48-300%
2007-HK$1.24-54.29%
2006-HK$2.72-67.89%
2005-HK$8.46-62.54%
2004-HK$22.57136.59%
2003-HK$9.54-15.17%
2002-HK$11.25-11.59%
2001-HK$12.7256.19%
2000-HK$8.1510.53%
1999-HK$7.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$79.44-1,415.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$11.17-284.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$21.88-462.16%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$24.67 308.43%๐Ÿ‡ซ๐Ÿ‡ท France
-HK$4.96-182.19%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$8.53 41.27%๐Ÿ‡บ๐Ÿ‡ธ USA